Nu Skin Enterprises Provides Update On Fourth-Quarter Results

        Nu Skin Enterprises Provides Update On Fourth-Quarter Results

Company Sees Significant Revenue Increase; Fifth Consecutive Record Year

PR Newswire

PROVO, Utah, Jan. 16, 2013

PROVO, Utah, Jan. 16, 2013 /PRNewswire/ -- In advance of an upcoming
presentation at the ICR XChange Conference, Nu Skin Enterprises, Inc. (NYSE:
NUS) today provided an update on anticipated results for the fourth quarter of
2012. The company now projects fourth-quarter revenue of approximately $588
million, representing growth of 19 percent over the prior year. The impact of
foreign currency exchange on revenue will be negligible for the quarter.
Earnings per share are estimated to be from $0.94 to $0.96. The company will
provide full details on its fourth-quarter results when it reports earnings on
Feb. 6, 2013.

"Our business continues to perform very well," said Truman Hunt, president and
chief executive officer. "When we forecasted results for 2012, we knew that we
faced a difficult fourth-quarter comparison as a result of recognizing
approximately $90 million of revenue from our product launch in the fourth
quarter of 2011. However, as a result of the dedicated efforts of our sales
leaders and corporate personnel around the world, revenue growth will be 19
percent in the fourth quarter, surpassing prior revenue guidance by $58
million."

The company's estimated revenue of $2.17 billion for the year represents
growth of more than 24 percent in 2012, the company's fifth consecutive record
year. Earnings growth is anticipated to be approximately 30 percent. In
addition, the company repurchased $200 million of its stock during the year,
approximately 7 percent of total shares outstanding. The company also recently
announced its intention to significantly increase its dividend payment by 50
percent beginning with the first dividend in 2013, resulting in an increase of
140 percent in dividend payout over the last three years.

"We continue to believe that 2013 will be yet another record year. As
forecasts become clearer for our ageLOC weight management launch in the back
half of 2013, we look forward to updating the market on our full-year
guidance. We see great enthusiasm building for this launch, reinforcing our
forecast for strong results," concluded Hunt.

Ritch Wood, the company's chief financial officer, will be presenting at the
ICR XChange conference on Jan. 17 at noon (EDT). Those wishing to access the
webcast and accompanying slides can visit the Investor Relations page on Nu
Skin Enterprises' website, http://ir.nuskin.com. An archive of the webcast
will be available at this same URL through Feb, 1, 2013.

About Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its
comprehensive anti-aging product portfolio, independent business opportunity
and corporate social responsibility initiatives. The company's scientific
leadership in both skin care and nutrition has established Nu Skin as a
premier anti-aging company. The company's anti-aging products feature the new
ageLOC^® suite of products including the ageLOC^® R^2 nutritional supplement,
ageLOC^® Galvanic Spa System and ageLOC^® Galvanic Body Spa™, as well as the
ageLOC^® Transformation daily skin care system. A global direct selling
company, Nu Skin operates in 53 markets worldwide and has more than 900,000
active distributors and preferred customers. Nu Skin is traded on the New York
Stock Exchange under the symbol 'NUS'. More information is available at
http://www.nuskin.com.

Please Note: This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended that represent the
company's current expectations and beliefs. All statements other than
statements of historical fact are "forward-looking statements" for purposes of
federal and state securities laws and include, but are not limited to,
statements of management's expectations regarding the company's performance,
initiatives, strategies and new product introductions; statements of estimates
or projections regarding revenue, earnings per share, foreign currency impact,
the amount and timing of future dividend payments and other financial items;
statements of belief; and statements of assumptions underlying any of the
foregoing. In some cases, you can identify these statements by forward-looking
words such as "believe," "expect," "project," "anticipate," "estimate,"
"intend," "plan," "targets," "likely," "will," "would," "could," "may,"
"might," the negative of these words and other similar words.

The forward-looking statements and related assumptions involve risks and
uncertainties that could cause actual results and outcomes to differ
materially from any forward-looking statements or views expressed herein.
These risks and uncertainties include, but are not limited to, the following:

  oestimates and guidance concerning anticipated revenue, earnings per share
    and the impact of foreign currency are preliminary estimates, and actual
    results may differ from the estimates and guidance provided based on a
    number of factors, including higher than anticipated expenses, changes in
    reserves, and year-end and other financial statement or audit adjustments;
  othe actual declaration and payment of the planned dividends by the Board
    of Directors is subject to any changes in the company's net earnings,
    financial condition, cash requirements, future prospects or other factors
    deemed relevant by the company's board of directors that could cause the
    Board of Directors to reduce or discontinue the payment of currently
    planned quarterly dividends;
  oany failure of current or planned initiatives or products to generate
    interest among distributors and customers and generate sponsoring and
    selling activities on a sustained basis;
  orisks related to accurately predicting, delivering or maintaining
    sufficient quantities of products to support our planned initiatives or
    launch strategies, including possible ingredient supply limitations;
  ochallenging economic conditions globally;
  orisk of foreign currency fluctuations and the currency translation impact
    on the company's business associated with these fluctuations;
  orisks associated with general inquiries and complaints to consumer
    protection agencies in Japan regarding the activities of some
    distributors;
  oregulatory risks associated with the company's products, which could
    require the company to modify its claims or inhibit the company's ability
    to import or continue selling a product in a market if it is determined to
    be a medical device or if it is unable to register the product in a timely
    manner under applicable regulatory requirements;
  ocontinued regulatory scrutiny and investigations in Mainland China, which
    have from time to time in the past, and could in the future, negatively
    impact the company's business, including the interruption of sales
    activities in stores, loss of licenses, and the imposition of fines;
  oadverse publicity related to the company's business, products, industry or
    any legal actions or complaints by distributors or others;
  oany prospective or retrospective increases in duties on the company's
    products imported into the company's markets outside of the United States
    and any adverse results of tax audits or unfavorable changes to tax laws
    in the company's various markets; and
  ocontinued competitive pressures in the company's markets.

The company's financial performance and the forward-looking statements
contained herein are further qualified by a detailed discussion of associated
risks set forth in the documents filed by the company with the Securities and
Exchange Commission. The forward-looking statements set forth the company's
beliefs as of the date that such information was first provided and the
company assumes no duty to update the forward-looking statements contained in
this release to reflect any change except as required by law.

SOURCE Nu Skin Enterprises, Inc.

Website: http://www.nuskinenterprises.com
Contact: Investors — Scott Pond, +1-801-345-2657, spond@nuskin.com; Media —
Kara Schneck, +1-801-345-2116, kschneck@nuskin.com
 
Press spacebar to pause and continue. Press esc to stop.